title: Current management of dentin hypersensitivity.
abstract: OBJECTIVE
  The aim of the article was to present an overview of the management strategies of dentin hypersensitivity (DHS) and summarize and discuss the therapeutic options.
  
  
  METHODS
  A PubMed literature search was conducted to identify articles dealing with dentin hypersensitivity prophylaxis and treatment. We focussed on meta-analyses of available or controlled clinical trials.
  
  
  RESULTS
  DHS therapy should start with noninvasive individual prophylactic home-care approaches. In-office therapy follows with nerve desensitizing, precipitating, or plugging agents. If the hypersensitivity persists, depending on the hard and soft tissue components at reevaluation, i.e., presence or absence of cervical lesions and the gingival contour, adhesive restorations including sealing or mucogingival surgery may be an option. They allow for the establishment of a physicomechanical barrier. As the placebo effect may play an important role, adequate patient management strategies and positive reinforcement may improve the management of DHS in the future.
  
  
  CONCLUSIONS
  Lifelong maintenance under the premise of strict control of the causative factors is crucial in the management of DHS.
  
  
  CONCLUSIONS
  Clinicians are faced with a broad spectrum of therapeutic options. Therapy should not only focus on pain reduction or better elimination but also on the modification of the exposed cervical dentin area based on the defect type.
authors.affiliation: Clinic of Preventive Dentistry, Periodontology and Cariology, Centre of Dental and Oral Medicine, University of Zurich, Plattenstrasse 11, 8032, Zurich, Switzerland. patrick.schmidlin@zzm.uzh.ch
authors.forename: Patrick R
authors.initials: PR
authors.lastname: Schmidlin
authors.forename: Phlipp
authors.initials: P
authors.lastname: Sahrmann
mesh_terms: D001840:Dental Bonding; D003804:Dentin / Q000187:drug effects; D057133:Dentin Desensitizing Agents / Q000627:therapeutic use; D003807:Dentin Sensitivity / Q000517:prevention & control / Q000628:therapy*; D005881:Gingiva / Q000473:pathology; D006801:Humans; D019237:Tooth Cervix / Q000187:drug effects
chemical_list: D057133:Dentin Desensitizing Agents